je.st
news
Tag: infection
Can pollution help trees fight infection?
2015-06-30 23:02:00| Climate Ark Climate Change & Global Warming Newsfeed
ScienceDaily: Trees that can tolerate soil pollution are also better at defending themselves against pests and pathogens. "It looks like the very act of tolerating chemical pollution may give trees an advantage from biological invasion," says Dr Frederic E. Pitre of the University of Montreal and one of the researchers behind the discovery. Unexpectedly, whilst studying the presence of genetic information (RNA) from fungi and bacteria in the trees, the researchers found evidence of a very large amount of RNA...
Tags: fight
trees
infection
pollution
TGAC awarded 100k to combat sugar beet crop infection in the UK
2015-06-10 06:43:14| Sugar Industry News
The Plant & Microbial Genomics Group at TGAC has been awarded 100k towards the identification of the sources of infection and reinfection of the sugar beet crop across the UK.
Your Viral Infection History in a Single Drop of Blood
2015-06-05 02:40:42| Biotech - Topix.net
New technology developed by Howard Hughes Medical Institute researchers makes it possible to test for current and past infections with any known human virus by analyzing a single drop of a person's blood. The method, called VirScan, is an efficient alternative to existing diagnostics that test for specific viruses one at a time.
Weekly Overview: New Research Looks to Viruses to Treat Bacterial Infection in Pigs
2015-06-02 02:00:00| ThePigSite - Industry News
ANALYSIS - In this week's news, pig producers could soon be using viruses to treat bacterial infections thanks to exciting new research from the University of Leicester, UK.
Tags: research
overview
weekly
treat
Merck Submits U.S. New Drug Application for Grazoprevir/Elbasvir, an Investigational Once-Daily, Single Tablet Combination Therapy, for Treatment of Chronic Hepatitis C Genotypes 1, 4, and 6 Infection
2015-05-28 22:30:00| Merck.com - Research & Development News
Dateline City: KENILWORTH, N.J. KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the company has submitted a New Drug Application to the U.S. Food and Drug Administration (FDA) for grazoprevir/elbasvir (100mg/50mg), an investigational once-daily, single tablet combination therapy for the treatment of adult patients with chronic hepatitis C genotypes (GT) 1, 4 or 6 infection. Within 60 days of submission, the FDA will determine whether it will accept for review Merck's application as filed. Language: English Contact: MerckMedia:Doris Li, 908-246-5701orSarra Herzog, 908-740-1871orInvestors:Joe Romanelli, 908-740-1986orJustin Holko, 908-740-1879 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: and
single
application
treatment
Sites : [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] next »